1Kristensen M, Chu CQ, Eedy DJ, et al. Localization of tumour necrosis factor-alpha(TNF-α)and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kDTNF receptor[J]. Clin Exp Immunol,1993, 94(2) :354 - 362.
3Bonifati C, Carducci M, Cordiali-Fei P, et al. Correlated increases of tumour necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients-relationships with disease severity[J]. Clin Exp Dermatol, 1994, 19(5) :383 - 387.
4Partsch G, Steiner G, Leeb BF, et al. Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid [J]. J Rheumatol, 1997, 24(3):518-523.
5Chodorowska G. Plasma concentrations of IFN- γ and TNF-αin psoriatic patients before and after local treatment with dithranol ointment [J]. J Eur Acad Dermatol Venereol,1998, 10(2): 147- 151.
6Mizutani H, Ohmoto Y, Mizutani T, et al. Role of increased production of monocytes TNF-α, IL-1β and IL-6 in psoriasis:relation to focal infection, disease activity and responses to treatments[J]. J Dermatol Sci, 1997, 14(2):145- 153.
7Ezepchuk YV, Leung DY, Middleton MH, et al. Staphylococcal toxins and protein A differentially induce cytotoxicity and release of tumor necrosis factor-alpha from human keratinocytes[J]. J Invest Dermatol, 1996, 107(4):603 -609.
8Yamamoto T, Katayama I, Nishioka K. Clinical analysis of staphylococcal superantigen hyper-reactive patients with psorisis vulgaris[J]. Eur J Dermatol, 1998, 8(5):325 -329.
10Reich K, Mossner R, Konig IR, et al. Promoter polymorphisms of the genes encoding tumor necrosis factor-alpha and interleukin-1beta are associated with different subtypes of psoriasis characterized by early and late disease onset[J]. J Invest Dermatol, 2002, 118(1):155- 163.
